About this trial
The goal of this study is to investigate the short-term changes in choroidal thickness and efficacy of the study spectacle lenses in children. Participants will be prescribed with a pair of study spectacle lenses for daily use and visit the clinic once every week for the first month for checkup and tests. After the first month of follow-up, participants will visit at 1 month, 6- and 12-month for checkup. Choroidal thickness, axial length and refractive errors will be monitored.
Eligibility criteria
Qualifiers
Hong Kong Chinese
Age at enrolment: 6 - 13 years
Myopia in spherical power: -1.00D to -5.00D in both eyes
Astigmatism: equal or less than 2.00D
Disqualifiers
Previous or current treatment for myopia control (e.g., red-light therapy, atropine, orthokeratology, specialized spectacle lenses and contact lenses and oral supplements for myopic control)
Existing or past eye diseases or surgeries (e.g., strabismus surgery, amblyopia, oculomotor nerve palsies, corneal disease, intraocular disease, etc.) that may have an impact on vision or visual development
Long-term medication (intake at least 3 days/week) or medication/supplements that affect eye health
Systemic diseases that may have an impact on vision or visual development (e.g., endocrine, cardiac and respiratory diseases, diabetes, Down syndrome, etc.)
Trial design
Treatments tested in this trial
- Modified Defocus Incorporated Multiple Segments lens (D1)
- Modified Defocus Incorporated Multiple Segments lens (D2)
Treatment groups
Locations
Sponsors and collaborators
The Hong Kong Polytechnic University
Lead sponsor
HOYA Lens Thailand LTD.
Collaborator